
Medtronic plc (MDT)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutMedtronic enters its fiscal second-quarter report with improved recent momentum, supported by raised fiscal 2027 guidance, strong cash flow, and growth in cardiac ablation products. The company also completed its MiniMed separation, while investors continue weighing sluggish organic growth, competitive pressure, and long-term underperformance. Analysts expect $1.34 in quarterly EPSand $9.47 billion in revenuefor the upcoming report.[1][2][3][4]











